Open AccessHuman anti‐ Pseudomonas aeruginosa outer membrane proteins IgG cross‐protective against infection with heterologous immunotype strains of P. aeruginosa 1, 2
Author(s) -
Lee NaGyong,
Ahn BoYoung,
Jung Sang Bo,
Kim Young Gi,
Lee Younha,
Kim HyunSu,
Park Wan Je
Publication year - 1999
Publication title -
fems immunology & medical microbiology
Language(s) - English
Resource type - Journals
eISSN - 1574-695X
pISSN - 0928-8244
DOI - 10.1111/j.1574-695x.1999.tb01358.x
Subject(s) - pseudomonas aeruginosa , microbiology and biotechnology , heterologous , biology , antibody , bacterial outer membrane , immunoglobulin g , pseudomonadaceae , titer , bacteria , immunology , escherichia coli , gene , biochemistry , genetics
In order to develop an effective means to treat and prevent Pseudomonas aeruginosa infections, we have purified P. aeruginosa outer membrane protein (Oprs)‐specific human IgG antibody using a large‐scale affinity column. In this study, we investigated the cross‐protective activity of the purified anti‐Oprs IgG against various immunotype strains of P. aeruginosa . The anti‐Oprs IgG reacted with Oprs isolated from seven Fisher‐Devlin immunotype strains of P. aeruginosa and was able to promote opsonophagocytic killing of all seven immunotype strains by human phagocytic cells. Administration of 500 μg anti‐Oprs IgG to mice raised the LD 50 of the P. aeruginosa strains by 8–250‐fold, indicating the protective capacity against heterologous P. aeruginosa strains as well as homologous strains. In contrast, despite high titers against P. aeruginosa Oprs, total serum IgG isolated from burn patient sera was no better than normal serum IgG in protecting mice from infection with P. aeruginosa . These data demonstrate that the affinity‐purified human anti‐Oprs IgG could afford protection against heterologous immunotype P. aeruginosa strains and provide a rationale to use anti‐Oprs IgG as an adjunct for treatment of P. aeruginosa infections in humans.